HLS Therapeutics (HLS Therapeutics) Accumulated other comprehensive income (loss) : $-2.84 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is HLS Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. HLS Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2023 was $-2.84 Mil.

HLS Therapeutics's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2023 ($-2.87 Mil) to Sep. 2023 ($-5.02 Mil) but then increased from Sep. 2023 ($-5.02 Mil) to Dec. 2023 ($-2.84 Mil).

HLS Therapeutics's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 ($2.96 Mil) to Dec. 2022 ($-5.26 Mil) but then increased from Dec. 2022 ($-5.26 Mil) to Dec. 2023 ($-2.84 Mil).

HLS Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for HLS Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Accumulated other comprehensive income (loss) Chart

HLS Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-0.54

2.02

2.96

-5.26

-2.84

HLS Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-5.26	-5.17	-2.87	-5.02	-2.84

HLS Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

HLS Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics (HLS Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (OTCPK:HLTRF) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

HLS:Canada

Address

10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2

Website

https://www.hlstherapeutics.com

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

HLS Therapeutics (HLS Therapeutics) Headlines

From GuruFocus

Automodular Corp. (TSX:AM) - Strong Buy

By Elliot Luchansky, CFA Elliot Luchansky, CFA • 03-21-2013